Progyny

Progyny EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Progyny (PGNY) as of Nov 12, 2026 is 7.70. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 8.96 — a change of -13.99% (lower).

EV/FCF

7.70

YoY

-13.99%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Progyny is 2025 7.70 . EV/FCF (Enterprise Value to Free Cash Flow) of Progyny was 2024 8.96 . It decreases by -13.99% lower compared to the previous year.

The Progyny EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
1,053.69 USD
Jan 1, 2019
-379.36 USD
Jan 1, 2020
47.61 USD
Jan 1, 2021
69.61 USD
Jan 1, 2022
20.67 USD
Jan 1, 2023
7.63 USD
Jan 1, 2024
8.96 USD
Jan 1, 2025
7.70 USD
The Progyny EV/FCF history
YEAREV/FCFYoY
7.70-13.99%
8.96+17.40%
7.63-63.08%
20.67-70.31%
69.61+46.20%
47.61-112.55%
-379.36-136.00%
1,053.69-695.64%
-176.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Progyny Stock analysis

What does Progyny do? Progyny Inc. is a company specializing in reproductive medicine and fertility treatments. It was founded in New York City in 2008 and has been listed on the NASDAQ stock exchange since 2019. The idea for Progyny arose when founder Gina Bartasi herself had difficulty getting pregnant and was searching for support and transparent information. She recognized the need to offer a better and more accessible service for people with fertility problems, thus founding Progyny. Progyny's business model is to offer employers a fertility benefit to help their employees, especially women, with family planning. It provides customized fertility treatments and financial assistance through its innovative programs. This allows employers to position themselves as progressive and inclusive while also increasing the bond and well-being of their employees. The different divisions of Progyny include fertility management, fertility measurement and monitoring, and fertility benefits. The fertility management solutions provide companies with comprehensive care for their employees, including counseling and support on fertility and family planning. They also provide access to an exclusive network practice specializing in reproductive medicine, including in vitro fertilization (IVF) and egg donation. The fertility measurement and monitoring program offers a personalized fertility profile that allows employees to track their fertility status to maximize their chances of a successful pregnancy. Progyny utilizes advanced methods of artificial intelligence and machine learning for this purpose. Progyny's fertility benefits include financial support for fertility treatments and medications that are not normally covered by health insurance. Additionally, the company offers a unique membership option that provides unlimited access to master fertility practices for one year. Progyny also offers a comprehensive patient experience through world-leading doctors and a patented technology platform. The platform provides support in navigating the fertility process and ensures that patients receive the best possible medical and financial care. Overall, Progyny has a significant impact on the field of reproductive medicine. With an innovative solution tailored to the needs of employers and strong support for aspiring parents, the company achieves a higher success rate in pregnancy compared to traditional fertility treatments. Progyny's technology platform improves workflow efficiency and communication in the practice, leading to a better patient experience and greater engagement. Overall, Progyny offers a holistic solution for employers and employees tailored to the unique challenges of family planning and fertility. With innovative approaches and a focus on the well-being of female employees, the company has taken a unique position in the market and is expected to continue to play a strong role in the industry. Progyny is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Progyny stock

EV/FCF (Enterprise Value to Free Cash Flow) of Progyny is 7.70 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Progyny changed from 8.96 to 7.70, representing a -13.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Progyny since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Progyny with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Progyny

All Key Metrics — Progyny